News

Silhouetted man on a scale and next to a ruler. Next to him are four circles with icons for time of day, muscle mass, genetics, and drug toxicity.

It’s the same old thing, since 1916

MIT News

April 24, 2024

Based on one equation developed in 1916 using data from nine patients, chemotherapy dosing calculations do not account for several variables that can lead to toxicity or insufficient benefit in patients.

Described in Med and funded in part by the Bridge Project, the Traverso and Langer Labs developed CLAUDIA, a closed-loop drug delivery system designed to tailor doses of chemotherapy to individual patients for maximum safety and effectiveness.

Filter by

Filter by Title/Description

Filter by Topic

Filter by Year

Showing 1–10 of 549 stories

Stark wins V Scholar Award

V Foundation

July 8, 2024

Congratulations to Jessica Stark, one of a class of 15 recipients selected as part of the V Foundation’s A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research, aimed at addressing longstanding gender disparities in research. Stark studies the interplay between the immune system and glycans—cell surface sugars—and how to leverage it to improve cancer immunotherapy.

Deciphering T cell diversity

MIT News

June 28, 2024

MIT News profiled Michael Birnbaum’s efforts to develop large scale screening tools to decipher how diverse T cells recognize their targets. Birnbaum co-founded Kelonia, which is adapting the approach to reprogram T cells to target specific antigens directly inside the body to treat a broad range of diseases including cancer, autoimmune disorders, and viral infections.  

Cutting out CRISPR bias

Broad Institute

June 14, 2024

A Nature Communications study from the Boehm Group and Broad Institute collaborators highlights an ancestry bias that can cause CRISPR screens to miss cancer dependencies. To help address this bias, which stems from the guide RNAs used, the team built a website of data tools to help researchers determine the effect of ancestry on specific guides. Ongoing work by Boehm, Francisco Sánchez-Rivera, and collaborators is supported by the Bridge Project.  

DINO-mite DNA polymers

MIT News

June 13, 2024

Inspired partly by the movie “Jurassic Park,” the Johnson Lab has developed an amber-like DNA-encapsulating polymer dubbed T-REX (Thermoset-REinforced Xeropreservation), for freezer-free long-term DNA storage. DNA itself has vast storage capacity that can accommodate genetic and digital data—everything from an entire human genome to the Jurassic Park theme song.

Langer named Kavli Laureate

MIT News

June 12, 2024

Congratulations to Robert Langer, who received a 2024 Kavli Prize in Nanoscience! The award recognizes his innovations in engineered  nanomaterials for the controlled release of drugs and nanoparticles for the delivery of vaccines. Langer’s work has had immense impact on the treatment of a range of diseases including cancer and schizophrenia and was instrumental in the development of mRNA vaccines. 

Catalyzing scholarly engagement

MIT News

June 10, 2024

Jacks Lab alum Rodrigo Romero took part in the 2024 Catalyst Symposium, a three-day event hosted by the Department of Biology and the Picower Institute for Memory designed to promote engagement among MIT scholars and postdocs who excel in their field and are from backgrounds traditionally underrepresented in science. Romero presented his work on lineage plasticity in the tumor microenvironment.

An enhanced view of gene transcription

MIT News

June 5, 2024

Regulating when genes are expressed, enhancers are promising drug targets for genetic disorders—when researchers can find them. Enhancers can reside far from the genes they regulate and leave only tiny amounts of eDNA, short-lived clues to their activation. Sharp Lab researchers led by postdoc D.B. Jay Mahat invented a technique, described in Nature, to facilitate eDNA isolation and observe coordination of gene expression and enhancer activation.

This work was supported in part by the Emerald Foundation.

Kinase atlas complete

MIT News

June 3, 2024

In a new Nature paper, the Yaffe Lab and collaborators map tyrosine kinase enzymes to their targets. This study, partly supported by the Charles and Marjorie Holloway Foundation and the L. Scott Ritterbush fund, builds on recent work mapping the other major kinase families to form a complete kinase atlas. This tool will enable researchers to map cell signaling pathways with unprecedented speed and detail, uncovering new biological insights and therapeutic targets for cancer.
 

Brio trio

MIT News

May 20, 2024

Of MIT’s 11 Fulbright winners this year, three hail from KI labs. Anusha Puri (Weinberg) is headed to the Swiss Institute for Experimental Cancer Research in Lausanne; Charvi Sharma (Yaffe) will teach English in Spain before resuming her clinician-scientist career path; and Isabella Witham (Belcher) is off to Seoul National University’s Biomimetic Materials and Stem Cell Engineering Lab.
The U.S. Department of State’s Fulbright U.S. Student Program offers one-year opportunities for overseas research, graduate study, or English language teaching to American students and recent alums.  

RNAi: An MIT case study

MIT News

May 13, 2024

Coinciding with the 50th anniversary of cancer research at MIT, a feature story tracing Alnylam’s success in developing RNAi therapies perfectly encapsulates the transformational impact and disciplinary diversity that characterize our community.  Incorporating contributions from the Sharp and Langer Labs, with their alumni and colleagues, Alnylam has several medicines approved by the FDA and a rapidly expanding clinical pipeline.